Characterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular Models
Creators
- 1. Centre for Chromosome Biology, School of Natural Sciences National University of Ireland Galway, Galway (Ireland)
- 2. Department of Haematology, Galway University Hospital, Galway (Ireland)
- 3. Department of Medicine, National University of Ireland Galway, Galway (Ireland)
- 4. Nerviano Medical Sciences S.r.l., Via Pasteur 10, Nerviano 20014 (Italy)
Description
Two key features of myeloma cells are the deregulation of the cell cycle and the dependency on the expression of the BCL2 family of anti-apoptotic proteins. The cell division cycle 7 (CDC7) is an essential S-phase kinase and emerging CDC7 inhibitors are effective in a variety of preclinical cancer models. These compounds also inhibit CDK9 which is relevant for MCL-1 expression. The activity and mechanism of action of the dual CDC7/CDK9 inhibitor PHA-767491 was assessed in a panel of multiple myeloma cell lines, in primary samples from patients, in the presence of stromal cells and in combination with drugs used in current chemotherapeutic regimens. We report that in all conditions myeloma cells undergo cell death upon PHA-767491 treatment and we report an overall additive effect with melphalan, bortezomib and doxorubicin, thus supporting further assessment of targeting CDC7 and CDK9 in multiple myeloma
Availability note (English)
Available from http://dx.doi.org/10.3390/cancers5030901; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795371Additional details
Identifiers
Publishing Information
- Journal Title
- Cancers (Basel)
- Journal Volume
- 5
- Journal Issue
- 3
- Journal Page Range
- p. 901-918
- ISSN
- 2072-6694
INIS
- Country of Publication
- Switzerland
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 47001842
- Subject category
- S60: APPLIED LIFE SCIENCES; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- APOPTOSIS; CELL CYCLE; CELL DIVISION; CHARGES; DNA REPLICATION; NEOPLASMS
- Descriptors DEC
- DISEASES; NUCLEIC ACID REPLICATION
Optional Information
- Copyright
- Copyright (c) 2013 by the authors
- Notes
- PMCID: PMC3795371; PMID: 24202326; PUBLISHER-ID: cancers-05-00901; OAI: oai:pubmedcentral.nih.gov:3795371; licensee MDPI, Basel, Switzerland.; This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).